In silico investigation of ACE2 and the main protease of SARS-CoV-2 with phytochemicals from Myristica fragrans (Houtt.) for the discovery of a novel COVID-19 drug

Simple item page
dc.contributor.authorTassanee Ongtanasup
dc.contributor.authorSmith Wanmasae
dc.contributor.authorSiriwan Srisang
dc.contributor.authorChawan Manaspon
dc.contributor.authorSoiphet Net-anong
dc.contributor.authorKomgrit Eawsakul
dc.date.accessioned2026-05-08T19:14:29Z
dc.date.issued2022-7-25
dc.description.abstractcompounds have potential as effective medicines to combat the COVID-19 pandemic. However, to assess the therapeutic potential of these ligands, additional research is needed, which will use our findings as a foundation.
dc.identifier.doi10.1016/j.sjbs.2022.103389
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/14589
dc.publisherSaudi Journal of Biological Sciences
dc.subjectPiperaceae Chemical and Biological Studies
dc.subjectDrug-Induced Hepatotoxicity and Protection
dc.subjectCholinesterase and Neurodegenerative Diseases
dc.titleIn silico investigation of ACE2 and the main protease of SARS-CoV-2 with phytochemicals from Myristica fragrans (Houtt.) for the discovery of a novel COVID-19 drug
dc.typeArticle

Files

Collections

All